Evidence map›Paper›PMID 41651920›Full record

ArticleScientific reports2026

Predictors of unsuccessful tuberculosis treatment outcome in Bhutan: A retrospective study using comprehensive national tuberculosis surveillance data.

Thinley Dorji, Karchung Tshering, Lila Adhikari, Thinley Jamtsho, Pavitra Bhujel, Pema Lhaden, Norelle L Sherry, Chantel Lin, Justin T Denholm, Sonam Wangchuk and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Extensive Endemic Transmission of Multidrug-ResistantOpen forum infectious diseases · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Thinley DorjiKanglung Hospital, Ministry of Health, Trashigang, Bhutan. thinley.dorji1@unimelb.edu.au.
Karchung TsheringNational Tuberculosis Reference Laboratory, Royal Centre for Disease Control, Ministry of Health, Serbithang, Thimphu, Bhutan.
Lila AdhikariNational Tuberculosis Reference Laboratory, Royal Centre for Disease Control, Ministry of Health, Serbithang, Thimphu, Bhutan.
Thinley JamtshoRoyal Centre for Disease Control, Ministry of Health, Serbithang, Thimphu, Bhutan.
Pavitra BhujelNational Tuberculosis Reference Laboratory, Royal Centre for Disease Control, Ministry of Health, Serbithang, Thimphu, Bhutan.
Pema LhadenNational Tuberculosis Reference Laboratory, Royal Centre for Disease Control, Ministry of Health, Serbithang, Thimphu, Bhutan.
Norelle L SherryDepartment of Microbiology and Immunology at The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Chantel LinMicrobiological Diagnostic Unit, Public Health Laboratory, Department of Microbiology and Immunology at The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Justin T DenholmRoyal Melbourne Hospital, Melbourne, Victoria, Australia.
Sonam WangchukRoyal Centre for Disease Control, Ministry of Health, Serbithang, Thimphu, Bhutan.
Kristy HoranDepartment of Microbiology and Immunology at The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Benjamin P HowdenDepartment of Microbiology and Immunology at The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Patiyan AnderssonDepartment of Microbiology and Immunology at The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia. patiyan.andersson@unimelb.edu.au.

Funding

National Health and Medical Research Council APP1105905
6 · The paper itself

Abstract

Despite the high burden of tuberculosis in Bhutan, data on treatment outcomes are limited. Using a national TB dataset from 2018 to 2021, provided by the National Tuberculosis Reference Laboratory, we conducted a retrospective cohort study to assess treatment outcomes and explore factors associated with unsuccessful TB outcomes. Of the 3,619 patients who received TB treatment, 3,330 had a recorded treatment outcome. Among these, 96.2% (n = 3,202) had a successful outcome (44.4% (n = 1,480) were cured and 51.7% (n = 1,722) completed treatment), and 3.8% (n = 128) had an unsuccessful outcome (2.8% (n = 93) died, 0.7% (n = 23) experienced treatment failure, and 0.4% (n = 12) were lost to follow-up). Multivariable logistic regression showed patients older than 60 years of age (aOR 4.3; 95% CI 2.09-10.0; p-value < 0.001), diagnosed in 2019 (aOR 1.7; 95% CI 1.03–2.86; p-value 0.041), 2021 (aOR 1.74; 95% CI 1.03–2.97; p-value 0.038), and pulmonary TB (aOR 2.69; 95% CI 1.76–4.27; p-value < 0.001) were more likely to have an unsuccessful treatment outcome. The proportion of successful TB treatment exceeded the global target rate of 90%, with a low rate of unsuccessful outcomes. Patients with pulmonary TB and elderly patients require active follow-up to ensure their treatment success increases. In-depth studies need to be conducted to understand the circumstances leading to the treatment failures and death.

Indexed as

Antitubercular AgentsTuberculosisAdolescentAdultAgedAged, 80 and overBhutanChildChild, PreschoolEpidemiological MonitoringFemaleHumansInfantInfant, NewbornMaleMiddle AgedAntitubercular AgentsBhutanTreatment outcomeTuberculosisUnsuccessful outcome

Identifiers

PMID41651920
PMCPMC12932646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.